Expansion & Growth Brainomix is actively expanding operations in the United States with a new funding extension of £4.8m to scale its presence, presenting a clear sales opportunity to support deployment, integration, and regional support across US healthcare networks and hospitals.

AI Imaging Leadership With the launch of Brainomix 360 Stroke Next Generation and novel net water uptake technology, there is a strong opportunity to engage radiology departments and stroke centers seeking cutting-edge AI tools to enhance diagnostic accuracy, throughput, and decision-making in acute care.

Strategic Partnerships Existing collaboration with Argenica Therapeutics highlights potential for co-development and imaging biomarkers partnerships, suggesting avenues to co-sell or bundle solutions with neuroprotection trials and stroke pathways.

Hospital Network Reach Deployment of Brainomix 360 Stroke across WVU Health System and a global footprint imply substantial interest from academic medical centers and large health systems for scalable AI-assisted imaging workflows that can be replicated across campuses.

End-to-End Workflow Fit Brainomix emphasizes seamless integration into current radiology workflows and broad stakeholder reach (neurologists, interventionalists, radiologists), signaling sales potential for turnkey implementation, training, and ongoing support within existing IT infrastructures.